SBU’s Paz no longer serving as executive VP for health science, Wertheim appointed on interim basis
Two years after he joined Stony Brook University as executive vice president for health sciences, Dr. Harold “Hal” Paz is no longer one of the most senior members of New York State’s southern flagship university staff.
An internal SBU announcement that went out Friday, Oct. 6, from the office of President Maurie McInnis indicated that Paz, whose page on the Renaissance School of Medicine website no longer links to information about him, will be replaced on an interim basis by Dr. William Wertheim.
Wertheim joined Stony Brook in 1996 and had been serving as the vice dean for graduate academic affairs at the Renaissance School of Medicine, where he had previously been interim dean.
Wertheim is also an Endowed Chair in Graduate Medical Education at the School of Medicine and is president of the Stony Brook Medicine Community Medical Group.
While Stony Brook didn’t offer a reason for Paz’s departure, officials indicated it is “not our practice to discuss personnel matters.”
Paz had come to SBU from The Ohio State University, where he was executive vice president and chancellor for health affairs and chief executive officer of the Ohio State Wexner Medical Center.
Paz, who was Chief Executive Officer of Stony Brook University Medicine, reported to McInnis and was a member of her senior leadership team.
When Stony Brook announced that executive vice president and provost Carl Lejuez joined the university in May 2022, the university signaled that Lejuez would work collaboratively with Paz.
Paz had also been working with academic, hospital and clinical leadership and with community partners in his role.
The announcement of Paz’s departure from SBU, which came two years and two days after his official start date, did not include a list of any of Paz’s achievements, initiatives or contributions to the university.
Before joining The Ohio State University, Paz was the executive vice president and chief medical officer for CVS Health/Aetna, serving as a leader in the company’s domestic and global businesses. He also served as dean of the College of Medicine at Pennsylvania State University and CEO of the Penn State Hershey Medical Center and Health System.
Paz had succeeded Dr. Kenneth Kaushansky, who retired as senior vice president of health sciences, in June 2021.
Paz serves on the National Academy of Medicine Leadership Consortium, the board of directors of Research America and the Curai Health advisory board.
In April, Paz was appointed to the National Academies of Sciences, Engineering and Medicine Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life committee.
Wertheim’s tenure
Wertheim started his Stony Brook career by leading the Medical Consult Services. He later served as associate program director and director of the primary care track of the Internal Medicine residency, then Internal Medicine residency program director, and then executive vice chair of the Department of Medicine and associate dean for clinical outreach.
Wertheim has also served as the president of the medical staff at Stony Brook University Hospital.
Wertheim graduated from Harvard University and New York University School of Medicine. He completed his residency at the University of Michigan Hospitals, where he served as chief resident.
Wertheim worked as a clinical faculty member at the University of Michigan’s Veterans Administration Hospital. In New York, he worked at The Brooklyn Hospital Center.
The letter from the president’s office announcing the changes urged the community to “join us in congratulating Dr. Wertheim on his appointment and welcoming him to his new role.”
